SCHEMBL3575259

SCHEMBL3575259

CC(C)Nc1ccc(Cl)cc1C(=O)N(CCc1cccc(C(F)(F)F)c1)Cc1ccc(C(F)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGES O14684 3/20 0.39
PLA2G1B P04054 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
CNR1 P21554 1/20 0.38
HSPH1 Q92598 1/20 0.38
SNCA P37840 1/20 0.38
MPO P05164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571486 0.92 LMNA (0.41) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3576622 0.89 LMNA (0.37) LMNASLC2A1C5AR1
SCHEMBL3582819 0.88 LMNA (0.38) LMNASMN1; SMN2GAASLC2A1C5AR1
SCHEMBL3586635 0.87 LMNA (0.39) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3583400 0.87 LMNA (0.39) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3579622 0.84 CETP (0.43) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3586185 0.84 LMNA (0.43) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3575609 0.83 LMNA (0.43) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3583512 0.82 LMNA (0.41) LMNAHPGDMEN1CYP1A2CYP3A4
SCHEMBL3579684 0.82 CNR1 (0.40) LMNAATMPTGESCNR1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed
CN-101379036-B Anthranilamide/2-amino-heteroarene carboxamide derivatives HOFFMANN LA ROCHE 2011-06-01 CN disclosed
CN-101379036-A Anthranilamide/2-amino-heteroarene carboxamide derivatives HOFFMANN LA ROCHE (CH) 2009-03-04 CN disclosed